204 related articles for article (PubMed ID: 23548950)
1. [Paget's disease of bone: new therapeutic strategies].
D'Amore M; Lisi S; Sisto M; De Marino AV
Recenti Prog Med; 2013 Mar; 104(3):89-92. PubMed ID: 23548950
[TBL] [Abstract][Full Text] [Related]
2. Etiology of Paget's disease and osteoclast abnormalities.
Reddy SV
J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
[TBL] [Abstract][Full Text] [Related]
3. Paget's disease: a clinical review.
Shah M; Shahid F; Chakravarty K
Br J Hosp Med (Lond); 2015 Jan; 76(1):25-30. PubMed ID: 25585180
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Paget's disease of bone.
Ralston SH
Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
[TBL] [Abstract][Full Text] [Related]
5. [Paget's disease: case report].
Wegierska M; Ignaczak P; Zalewska J; Jeka S
Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of Paget's disease].
Kurth AA
Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256
[TBL] [Abstract][Full Text] [Related]
7. Etiologic factors in Paget's disease of bone.
Reddy SV
Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
[TBL] [Abstract][Full Text] [Related]
8. Paget's disease of bone.
Tan A; Ralston SH
QJM; 2014 Nov; 107(11):865-9. PubMed ID: 24757095
[TBL] [Abstract][Full Text] [Related]
9. Paget's disease of bone: a review.
Colina M; La Corte R; De Leonardis F; Trotta F
Rheumatol Int; 2008 Sep; 28(11):1069-75. PubMed ID: 18592244
[TBL] [Abstract][Full Text] [Related]
10. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP
J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687
[TBL] [Abstract][Full Text] [Related]
11. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Paget's Disease of Bone with Denosumab: Case Report and Literature Review.
Reid IR; Sharma S; Kalluru R; Eagleton C
Calcif Tissue Int; 2016 Sep; 99(3):322-5. PubMed ID: 27193832
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
14. [Paget's disease of bone].
Takata S
Nihon Rinsho; 2005 Oct; 63 Suppl 10():219-25. PubMed ID: 16279635
[No Abstract] [Full Text] [Related]
15. [Denosumab as the potent therapeutic agent against Paget's disease of bone].
Hirao M; Hashimoto J
Clin Calcium; 2011 Aug; 21(8):1231-8. PubMed ID: 21814030
[TBL] [Abstract][Full Text] [Related]
16. Insights into the pathogenesis of Paget's disease.
Roodman GD
Ann N Y Acad Sci; 2010 Mar; 1192():176-80. PubMed ID: 20392234
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapies to manage bone loss-associated diseases: a quest for the perfect benefit-to-risk ratio.
Valverde P
Curr Med Chem; 2008; 15(3):284-304. PubMed ID: 18288984
[TBL] [Abstract][Full Text] [Related]
18. Emerging strategies and therapies for treatment of Paget's disease of bone.
Michou L; Brown JP
Drug Des Devel Ther; 2011; 5():225-39. PubMed ID: 21607019
[TBL] [Abstract][Full Text] [Related]
19. Rare Inherited forms of Paget's Disease and Related Syndromes.
Ralston SH; Taylor JP
Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140
[TBL] [Abstract][Full Text] [Related]
20. [[Antiresorptive agents in the treatment of osteoporosis].
Novak S
Reumatizam; 2014; 61(2):89-94. PubMed ID: 25427401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]